CXMT (688825.SH)'s sixth-generation low-power double data rate memory standard (LPDDR6) is nearing the end of its R&D validation stage, marking an important step before mass production, according to a report by China Business Network citing sources.

As early as March 2026, market sources divulged that CXMT was actively advancing the commercialization of LPDDR6 products and had already provided samples to core customers. The products are expected to be launched and enter mass production in 2H26.

In addition, SK hynix Inc. (SKHY.US) has recently finalized its LPDDR6 mass production plan, while XIAOMI-W (01810.HK) is expected to become one of the first manufacturers to adopt the memory in flagship smartphone models, report told.
~

AASTOCKS Financial News
Website: www.aastocks.com

Moonshot AI reached a computing power agreement with BABA-W (09988.HK), allowing it to use about 20,000 Nvidia (NVDA.US) chips, Bloomberg, citing sources, reported.

The chips reportedly obtained by Moonshot AI through BABA-W came from Nvidia's earlier-generation Hopper product, the H200 chip, although BABA-W denied the claim.

A spokesperson for BABA-W said reports that the company supplied H200 chips to Moonshot AI were completely groundless, but did not deny providing related Nvidia chip computing power to Moonshot AI, and also declined to disclose the actual chip model used.
~

AASTOCKS Financial News
Website: www.aastocks.com

CONCORD NE (00182.HK) gapped up 14.08% at the open today (3rd), reaching a peak of HKD0.415. It last printed at HKD0.395, up 11.27%, with turnover of HKD5.9297 million.

CONCORD NE announced that the Company’s wholly owned subsidiaries in the US entered into three long-term Power Purchase Agreements (PPAs) with Tesla (TSLA.US) for solar projects in the US.

The long-term PPAs cover three solar projects with a total capacity of approximately 469 MW (AC). Upon full operation of all three projects, the Company will supply Tesla with approximately 1,200 GWh of electricity annually in the US. The first project is expected to commence power supply in the first half of 2027.
~

AASTOCKS Financial News
Website: www.aastocks.com

The three major US stock indices finished up 0.5-1% last Friday (31st), driven by a more than 15% post-results surge in Amazon.com, Inc. (AMZN.US). Japan and the US confirmed their joint intervention in the foreign exchange market last Friday. Japan's stock market plummeted more than 1,600 points this morning (3rd), while South Korea's stock market also slumped more than 4%.

However, the HSI opened at 25,987, up 102 pts or 0.4%; the HSCEI opened at 8,659, up 46 pts or 0.55%; and the HSTECH opened at 4,861, up 32 pts or 0.68%.

Major techs edged higher broadly. BABA-W (09988.HK) opened up 3.42%; BIDU-SW (09888.HK) opened up 2.83%; while TENCENT (00700.HK) and KUAISHOU-W (01024.HK) opened more than 1% higher.

Automakers released July sales data. GEELY AUTO (00175.HK) opened up 1.52% after Zeekr brand sales more than doubled in July; BYD COMPANY (01211.HK)'s July NEV sales mounted nearly 22% YoY, with the stock opening nearly 1% higher; CHERY AUTO (09973.HK) opened up 2.7%; while LI AUTO-W (02015.HK) sank 1.22%.

Among individual stocks, XUNCE (03317.HK), which issued a positive profit alert, opened 14.98% higher; TAI HING GROUP (06811.HK) spiked 5.93% as the company expected interim profit to soar by more than 76%.
~

AASTOCKS Financial News
Website: www.aastocks.com

• 高管團隊重磅擴容將加碼全球商業化進程

中國蘇州2026年8月3日 /美通社/ -- 致力於在腫瘤等領域開發創新藥物的領先的生物醫藥企業——亞盛醫藥（納斯達克代碼：AAPG；香港聯交所代碼：6855）今日宣佈，公司任命Faical Miyara博士為首席業務拓展官（Chief Business Officer，CBO），負責亞盛醫藥的全球業務拓展工作；並任命Jim Ziegler為首席商務運營官（Chief Commercial Officer，CCO），負責公司產品在大中華地區以外的全球市場的商業化運營。Miyara博士和Ziegler先生直接向公司董事長兼首席執行官楊大俊博士匯報。

Miyara博士在全球大型製藥公司和生物技術公司中擁有超過20年的腫瘤領域商務拓展經驗。加入亞盛前，他曾任IO Biotech首席業務拓展官兼高管團隊核心成員；更早之前，他任職益普生副總裁，全面負責腫瘤領域全球商務合作，項目搜尋評估，以及風險投資機構關係管理工作。Miyara博士還曾在輝瑞公司任職五年，共同發起並建立了輝瑞紐約治療創新中心（CTI），並出任多個研發高級崗位；此後在ImClone公司與禮來公司任職五年，直接參與多項獲美國FDA批准的知名腫瘤生物制劑的研發、優化和開發，包括愛必妥^®（西妥昔單抗）與希冉擇^®（雷莫西尤單抗）。Miyara博士擁有法國巴黎皮埃爾與瑪麗・居裡大學（即索邦大學）的生殖生物學、分子生物學與細胞生物學的博士學位，以及法國格勒諾布爾約瑟夫・傅裡葉醫學院的醫學生物學碩士暨工程師學位。他始終深耕科研創新，曾參與撰寫多部學術專著章節，在多個同行評議科學期刊上發表過多篇論文，並作為主要發明人擁有三項獨立專利。

Ziegler先生是資深的生物醫藥行業高管，擁有超過25年的商業化運營及管理經驗。他曾主導多款產品的全球損益管控，搭建並規模化擴張高效能業務團隊，積累了覆蓋多款專科療法的產品上市及商業化全週期操盤經驗。Ziegler先生在商業化戰略制定、市場准入、組織體系搭建等領域積澱深厚，能夠主導推動腫瘤、血液疾病等複雜專科市場的跨職能協作與商業化落地。他兼具大型成熟藥企與新興生物製藥企業的商業化深厚從業經驗，曾先後任職於安進、吉利德科學等行業龍頭藥企，以及Lovance Biotherapeutics、Geron等新興生物藥企，並在後兩家企業領導全球商業化團隊。進入生物製藥行業前，Ziegler先生曾服役於美國陸軍，擔任裝甲軍官。他擁有美國西點軍校理學學士學位，以及芝加哥大學工商管理碩士學位。

楊大俊博士表示：「我們由衷歡迎Faical Miyara博士和Jim Ziegler先生加入公司高管團隊。隨著多項全球註冊III期臨床的快速推進，亞盛醫藥作為港股、納斯達克雙重主要上市的全球性創新藥企業，正邁向全球化佈局新階段。兩位資深高管的加入，將極大助力公司的全球業務拓展和全球商業化佈局。 

Miyara博士是一位極具創新精神和戰略遠見的領導者，在構建高價值腫瘤業務發展管線方面擁有卓越經驗。我們相信在Miyara博士的助力下，能更好地賦能公司的國際業務拓展。

Ziegler先生擁有豐富的專科療法從業經驗，尤其深耕血液腫瘤領域，在產品上市、市場准入與醫保報銷、商業化體系搭建及全球商業化戰略佈局方面都有豐富經驗。當前亞盛醫藥多款血液腫瘤產品正邁向全球商業化階段，Ziegler先生的經驗與公司全球化發展戰略高度契合，能夠顯著增強公司全球商業化能力，加速建立世界級商業化體系。

再次歡迎兩位的加入，我們期待與Miyara博士和Ziegler先生攜手，進一步夯實公司在全球血液腫瘤領域的領先地位，為全球患者帶來更多治療選擇。」

Faical Miyara博士表示：「我非常榮幸能加入亞盛醫藥。亞盛醫藥正在邁入全球化佈局推進的全新階段，我期待與這支優秀的團隊緊密攜手，依托過往積累的經驗，全力推動公司全球戰略落地與業務版圖拓展，與公司共攀發展新高度。」

Jim Ziegler先生表示：「我十分高興能見證並參與亞盛醫藥全球化發展的關鍵階段。亞盛醫藥現已打造具備差異化優勢的創新管線，有望解決血液腫瘤領域重大的未被滿足的臨床需求。我非常期待能攜手公司團隊共同推動公司全球商業化戰略與能力建設，更快地為全球患者提供更多重要的全新治療選擇。」

關於亞盛醫藥

亞盛醫藥（納斯達克代碼：AAPG；香港聯交所代碼：6855）是一家綜合性的全球生物醫藥企業，致力於研發、生產和商業化創新藥，以解決腫瘤領域全球患者尚未滿足的臨床需求。公司已建立豐富的創新藥產品管線，包括抑制Bcl-2和 MDM2-p53 等細胞凋亡通路關鍵蛋白的抑制劑、新一代針對癌症治療中出現的激酶突變體的抑制劑以及蛋白降解劑。

公司核心品種耐立克^®是中國首個獲批上市的第三代BCR-ABL抑制劑，已獲批用於治療伴有T315I突變的慢性髓細胞白血病慢性期（CML-CP）和加速期（CML-AP）患者，以及對一代和二代TKI耐藥和/或不耐受的CML-CP成年患者。該藥物所有獲批適應症均已被納入中國國家醫保藥品目錄（NRDL）。目前，亞盛醫藥正在開展耐立克^®三項全球註冊III期臨床研究，分別為：獲美國FDA和歐洲EMA許可的評估耐立克^®治療新診斷費城染色體陽性急性淋巴細胞白血病（Ph+ ALL）患者POLARIS-1研究；獲美國FDA和歐洲EMA許可的評估耐立克^®治療經治CML-CP成年患者的POLARIS-2研究；評估耐立克^®治療SDH-缺陷型GIST患者的POLARIS-3研究。

公司另一重磅品種利生妥^®是一款用於治療多種血液系統惡性腫瘤的新型Bcl-2抑制劑。利生妥^®已獲中國國家藥品監督管理局（NMPA）批准，用於治療既往至少接受過一種包括布魯頓酪氨酸激酶（BTK）抑制劑在內的系統治療的成人慢性淋巴細胞白血病/小淋巴細胞淋巴瘤（CLL/SLL）患者。目前，亞盛醫藥正在開展利生妥^®四項全球註冊III期臨床研究，分別為：獲美國FDA和歐洲EMA許可的評估利生妥^®聯合BTK抑制劑治療既往接受BTK抑制劑治療超過12個月且應答不佳的CLL/SLL患者的GLORA研究；評估利生妥^®一線治療初治CLL/SLL患者的GLORA-2研究；評估利生妥^®一線治療新診斷老年或不耐受的AML患者的GLORA-3研究；以及獲美國FDA和歐洲EMA許可的評估利生妥^®一線治療新診斷中高危MDS患者的GLORA-4研究。

憑借強大的研發能力，亞盛醫藥已在全球範圍內進行知識產權佈局，並與武田、阿斯利康、默沙東、輝瑞、信達等眾多領先的生物製藥公司達成全球合作，同時與丹娜法伯癌症研究院、梅奧醫學中心、美國國家癌症研究所和密西根大學等學術機構建立研發合作關係。如需瞭解更多信息，請訪問 https://ascentage.com/

前瞻性聲明

本新聞稿包含根據美國《1995年私人證券訴訟改革法案》，以及經修訂的《1933年證券法》第27A條和《1934年證券交易法》第21E條所界定的前瞻性陳述。除歷史事實陳述外，本新聞稿中的所有內容均可能構成前瞻性陳述，包括亞盛醫藥對未來事件、經營成果或財務狀況所發表的意見、預期、信念、計劃、目標、假設或預測。

這些前瞻性陳述受到諸多風險和不確定性的影響，具體內容已在亞盛醫藥向美國證券交易委員會（SEC）提交的文件中詳細說明，包括2026年4月29日提交的20-F表格中截止2025年12月31日的年度報告中的「風險因素」和「關於前瞻性聲明的警示聲明」章節，2019年10月16日提交的首次發行上市招股書中的「前瞻性聲明」、「風險因素」章節，以及我們不時向SEC或HKEX提交的其他文件。這些因素可能導致實際業績、運營水平、經營成果或成就與前瞻性陳述中明示或暗示的信息存在重大差異。本前瞻性聲明中的陳述不構成公司管理層的利潤預測。

因此，該等前瞻性陳述不應被視為對未來事件的預測。本新聞稿中的前瞻性陳述僅基於亞盛醫藥當前對未來發展及其潛在影響的預期和判斷，且僅代表截至陳述發表之日的觀點。無論出現新信息、未來事件或其他情況，亞盛醫藥均無義務更新或修訂任何前瞻性陳述。

GUANGZHOU, China, Aug. 1, 2026 /PRNewswire/ -- XPeng Inc. ("XPENG" or the "Company," NYSE: XPEV and HKEX: 9868), a leading global Physical AI company, today announced its vehicle delivery results for July 2026.

XPENG delivered 38,027 vehicles in July, marking an increase of 4% year over year. As of July 31, 2026, the Company's cumulative deliveries reached a new milestone of more than 1.2 million units worldwide.

On July 16, XPENG held its Brand Day and the L03 Global Launch Event in Munich, Germany. The new global model will launch in 65 countries and regions this year, expanding XPENG's international product lineup.

On the global expansion front, earlier this month XPENG officially unveiled its long-term strategy for the Australian market, including plans to launch five all-new models in the second half of 2026 and continue expanding its local sales and service network. XPENG also announced that its NGP (Next Generation Pilot) system, powered by the in-house developed VLA 2.0 model, will begin its global rollout in 2027, bringing its intelligent driving technology to markets around the world.

XPENG's electric vehicles delivered from January to July 2026 are expected to reduce life-cycle greenhouse gas emissions by more than 3.23 million tons compared to internal combustion engine vehicles, equivalent to the carbon absorbed by 53.75 million young trees over 10 years.

About XPENG

XPENG is a leading global Physical AI company, dedicated to bringing artificial intelligence into the physical world to reshape future mobility and smart living. Through in-house R&D, XPENG has developed a full-stack Physical AI architecture spanning Turing AI chips, world foundation models, and highly integrated software and hardware applications. This unified technology foundation of XPENG powers an expansive product portfolio of smart EVs, robotaxis, and humanoid robots, advancing the deployment of Physical AI at scale. Headquartered in Guangzhou, China, XPENG is dual-primary listed on the New York Stock Exchange and the Hong Kong Stock Exchange. With global capabilities across R&D, manufacturing, sales, and services, XPENG drives continuous technological innovation and fosters an open Physical AI ecosystem, making life smarter, safer, and better for users worldwide. For more information, please visit https://www.xpeng.com/.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Statements that are not historical facts, including statements about XPENG's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: XPENG's goal and strategies; XPENG's expansion plans; XPENG's future business development, financial condition and results of operations; the trends in, and size of, China's EV market; XPENG's expectations regarding demand for, and market acceptance of, its products and services; XPENG's expectations regarding its relationships with customers, suppliers, third-party service providers, strategic partners and other stakeholders; general economic and business conditions; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in XPENG's filings with the United States Securities and Exchange Commission. All information provided in this announcement is as of the date of this announcement, and XPENG does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Contacts:

For Investor Enquiries:

IR Department
XPeng Inc.
Email: [email protected]

Jenny Cai
Piacente Financial Communications
Tel: +1 212 481 2050 / +86 10 6508 0677
Email: [email protected]

For Media Enquiries:

PR Department
XPeng Inc.
Email: [email protected]

HONG KONG, July 31, 2026 /PRNewswire/ -- Kuaishou Technology ("Kuaishou" or the "Company"; HKD Counter Stock Code: 01024 / RMB Counter Stock Code: 81024), a leading content community and social platform, today announced that it will report its unaudited consolidated results for the second quarter and half year ended June 30, 2026, after the Hong Kong market closes on Wednesday, August 19, 2026.

The Company's management will host a conference call on Wednesday, August 19, 2026, at 7:00 PM Beijing Time (7:00 AM U.S. Eastern Time) to discuss the results.

Participants are required to pre-register for the conference call at:

Chinese Line (Mandarin):
https://s1.c-conf.com/diamondpass/10055639-hu7y6t.html

English Simultaneous Interpretation Line (listen-only mode):
https://s1.c-conf.com/diamondpass/10055640-pk81aw.html 

Participants can choose between the Chinese and English simultaneous interpretation options for pre-registration above. Please note that the English simultaneous interpretation option will be in listen-only mode. Upon registration, participants will receive an email containing conference call dial-in details, event passcode, and a unique registrant ID. This information will allow you to gain immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.

Additionally, live, and archived webcasts of the conference call, for both Chinese and English simultaneous interpretation, will be available on the Company's investor relations website at https://ir.kuaishou.com.

Replays of the conference call will be available until August 26, 2026 via the following dial-in details:

About Kuaishou

Kuaishou is a leading content community and social platform in China and globally, committed to becoming the most customer-obsessed company in the world. Kuaishou uses its technological backbone, powered by cutting-edge AI technology, to continuously drive innovation and product enhancements that enrich its service offerings and application scenarios, creating exceptional customer value. Through short videos and live streams on Kuaishou's platform, users can share their lives, discover goods and services they need and showcase their talent. By partnering closely with content creators and businesses, Kuaishou provides technologies, products, and services that cater to diverse user needs across a broad spectrum of entertainment, online marketing services, e-commerce, local services, gaming, and much more. For more information, please visit https://ir.kuaishou.com.

For investor and media inquiries, please contact:

Kuaishou Technology
Investor Relations
Email: [email protected]

香港2026年7月31日 /美通社/ -- 領先的內容社區及社交平台快手科技（「快手」或「公司」；港幣櫃台股份代號：01024 / 人民幣櫃台股份代號：81024）今日宣布，將於2026年8月19日（星期三）在香港市場收市後公佈其截至2026年6月30日止未經審核的第二季度及上半年合併業績。

公司管理層將於2026年8月19日（星期三）北京時間晚上7:00（美國東部時間上午7:00）舉行電話會議，討論業績。

如欲參與電話會議，須通過鏈接預先登記：

中文專線（普通話）：
https://s1.c-conf.com/diamondpass/10055639-hu7y6t.html 

英文同聲傳譯專線（僅供聆聽）：
https://s1.c-conf.com/diamondpass/10055640-pk81aw.html 

參會者預先登記時可選擇中文專線或英文同聲傳譯專線。請注意，英文同聲傳譯專線僅供聆聽。完成登記後，參會者將會收到列有會議撥入詳情、會議密碼及特定登記號碼的電子郵件。參會者可使用相關訊息直接參與電話會議。參會者可在電話會議開始前及進行期間，隨時預先登記。

此外，公司投資者關係網站亦會提供電話會議（包括中文專線及英文同聲傳譯專線）的直播及存檔網絡廣播，網址為：https://ir.kuaishou.com/zh-hant。

可致電以下電話號碼收聽錄音重播，錄音有效期至2026年8月26日。

關於快手

快手作為中國乃至全球領先的內容社區及社交平台，致力於成為全球最癡迷于為客戶創造價值的公司。作為一家以人工智能為核心驅動和技術依託的科技公司，快手專注於通過持續的技術創新和產品升級，不斷豐富服務和應用場景，為客戶創造價值。在快手，用戶通過短視頻和直播來記錄和分享他們的生活，發現所需，發揮所長。通過與內容創作者和企業緊密合作，快手提供的技術、產品和服務可滿足用戶的多元化的需求，包括娛樂、線上營銷服務、電商、本地生活、遊戲等。有關快手的詳細資料，請瀏覽網站https://ir.kuaishou.com/zh-hant。

投資者及媒體查詢，請聯繫：

快手科技
投資者關係
電郵：[email protected]

HONG KONG, July 31, 2026 /PRNewswire/ -- Kuaishou Technology ("Kuaishou" or the "Company"; HKD Counter Stock Code: 01024 / RMB Counter Stock Code: 81024), a leading content community and social platform, today announced that it will report its unaudited consolidated results for the second quarter and half year ended June 30, 2026, after the Hong Kong market closes on Wednesday, August 19, 2026.

The Company's management will host a conference call on Wednesday, August 19, 2026, at 7:00 PM Beijing Time (7:00 AM U.S. Eastern Time) to discuss the results.

Participants are required to pre-register for the conference call at:

Chinese Line (Mandarin):
https://s1.c-conf.com/diamondpass/10055639-hu7y6t.html

English Simultaneous Interpretation Line (listen-only mode):
https://s1.c-conf.com/diamondpass/10055640-pk81aw.html 

Participants can choose between the Chinese and English simultaneous interpretation options for pre-registration above. Please note that the English simultaneous interpretation option will be in listen-only mode. Upon registration, participants will receive an email containing conference call dial-in details, event passcode, and a unique registrant ID. This information will allow you to gain immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.

Additionally, live, and archived webcasts of the conference call, for both Chinese and English simultaneous interpretation, will be available on the Company's investor relations website at https://ir.kuaishou.com.

Replays of the conference call will be available until August 26, 2026 via the following dial-in details:

About Kuaishou

Kuaishou is a leading content community and social platform in China and globally, committed to becoming the most customer-obsessed company in the world. Kuaishou uses its technological backbone, powered by cutting-edge AI technology, to continuously drive innovation and product enhancements that enrich its service offerings and application scenarios, creating exceptional customer value. Through short videos and live streams on Kuaishou's platform, users can share their lives, discover goods and services they need and showcase their talent. By partnering closely with content creators and businesses, Kuaishou provides technologies, products, and services that cater to diverse user needs across a broad spectrum of entertainment, online marketing services, e-commerce, local services, gaming, and much more. For more information, please visit https://ir.kuaishou.com.

For investor and media inquiries, please contact:

Kuaishou Technology
Investor Relations
Email: [email protected]

Amazon.com, Inc. (AMZN.US) shares leaped 12% in pre-market trading on Friday (31st), while Apple Inc. (AAPL.US) fell off 7%, reflecting markedly different investor reactions to the two companies' quarterly results for the period ended June.

Both companies announced quarterly results for the period ended June 2026 on Thursday, with Amazon.com, Inc. receiving a positive market response while Apple Inc. disappointed investors.

Apple Inc.'s quarterly profit, revenue and iPhone sales all topped market expectations, but the company issued weak guidance for the current quarter, citing the impact of supply constraints. Apple Inc. said revenue growth for the current quarter would range between 9% and 11%, below market expectations for 12% growth.
~

AASTOCKS Financial News
Website: www.aastocks.com